Clinical Trial - Trial ChiCTR2200056410
Access comprehensive clinical trial information for ChiCTR2200056410 through Pure Global AI's free database. This Phase 4 trial is sponsored by Tianjin Medical University Chu Hsien-I Memorial Hospital and is currently Not yet recruiting. The study focuses on Type 2 Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200056410
Phase 4
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200056410
View on Chinese Clinical Trial Registry
Untitled Trial
A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Polyethylene glycol loxenatide on Cardiovascular Outcomes in patients with Type 2 Diabetes (BALANCE-3)
Study Focus
Sponsor & Location
Tianjin Medical University Chu Hsien-I Memorial Hospital
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
China
Timeline & Enrollment
Phase 4
N/A
Apr 30, 2026
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
Chinese Clinical Trial Registry
ChiCTR2200056410
Non-Device Trial